Senolytics: the science of clearing the body's 'zombie cells'
Aging cells that refuse to die quietly may drive inflammation. Here's where the research actually stands.
4h ago4 min read
Source
AI summary — public lecture, cellular-aging researcher
Senescent or 'zombie' cells stop dividing but won't die, releasing a cocktail of inflammatory molecules that researchers link to many age-related conditions.
Drugs called senolytics aim to flush them out. In mice the results are dramatic; in humans the first small trials are encouraging but far from conclusive.
The researcher's practical note: regular exercise and good metabolic health already reduce senescent-cell burden — no prescription required.
Key takeaways
1Senescent cells accumulate with age and leak inflammatory signals.
2Animal studies are striking; human trials are early but promising.
3Exercise already clears some of these cells naturally.
Educational summary of publicly available talks and research. Not medical advice — always consult a qualified professional.